• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一种用于大肠癌根治性手术后患者随访的省时但有效的方法。

A time-saving but effective approach to the follow-up of patients after curative surgery for carcinoma of the large bowel.

作者信息

Ross A P

出版信息

Ann R Coll Surg Engl. 1983 Jan;65(1):8-10.

PMID:6824311
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2494197/
Abstract

The traditional methods of follow-up of patients after curative surgery for large-bowel carcinoma have been shown to be time-consuming but largely ineffectual. A new approach is proposed which utilises laboratory investigations. A plea is made for controlled trials of cytotoxic regimens in patients with proven recurrent disease.

摘要

已证明，对大肠癌患者进行根治性手术后的传统随访方法既耗时又大多无效。现提出一种利用实验室检查的新方法。对于已证实复发疾病的患者，呼吁对细胞毒性治疗方案进行对照试验。

相似文献

1
A time-saving but effective approach to the follow-up of patients after curative surgery for carcinoma of the large bowel.一种用于大肠癌根治性手术后患者随访的省时但有效的方法。
Ann R Coll Surg Engl. 1983 Jan;65(1):8-10.
2
A time saving but effective approach to the follow-up of patients after curative surgery of the large bowel.一种用于大肠根治性手术后患者随访的省时且有效的方法。
Ann R Coll Surg Engl. 1984 Mar;66(2):145.
3
A new approach in carcinoembryonic antigen-guided follow-up of large-bowel carcinoma patients.一种用于大肠癌患者癌胚抗原引导随访的新方法。
Scand J Gastroenterol. 1986 Aug;21(6):641-9. doi: 10.3109/00365528609011095.
4
The follow-up of patients after resection for large bowel cancer, May 1992.1992年5月，大肠癌切除术后患者的随访情况。
Med J Aust. 1993 Feb 15;158(4):287.
5
Monitoring of patients with carcinoma of the large intestine by use of acute phase proteins and carcinoembryonic antigen.
Surg Gynecol Obstet. 1983 Jun;156(6):777-80.
6
Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.癌胚抗原用于检测结直肠癌根治性切除术后的复发疾病。
Anticancer Res. 2000 Nov-Dec;20(6D):4953-5.
7
[Diagnostic importance of colonoscopy in patients operated on previously for cancer of the large intestine].[结肠镜检查对既往接受过大肠癌症手术患者的诊断重要性]
Vestn Khir Im I I Grek. 1980 Dec;125(12):74-6.
8
[Adjuvant chemotherapy following radical operations for cancer of the large intestine].[大肠癌根治术后的辅助化疗]
Vopr Onkol. 1985;31(5):10-4.
9
[Surgical treatment of malignant polyps of the large intestine].[大肠恶性息肉的外科治疗]
Vopr Onkol. 1982;28(8):55-60.
10
[The value of follow-up studies after surgery of carcinoma of the large intestine].[大肠癌手术后随访研究的价值]
Ned Tijdschr Geneeskd. 1987 Mar 21;131(12):496-500.

引用本文的文献

1
Symposium: The management of recurrent colorectal cancer.
Int J Colorectal Dis. 1986 Jul;1(3):133-51. doi: 10.1007/BF01648440.

本文引用的文献

1
Outpatient follow-up after curative surgery for carcinoma of the large bowel.大肠癌根治性手术后的门诊随访。
Br Med J. 1980 Mar 29;280(6218):937. doi: 10.1136/bmj.280.6218.937-c.
2
Value of outpatient follow-up after curative surgery for carcinoma of the large bowel.大肠癌根治性手术后门诊随访的价值。
Br Med J. 1980 Mar 1;280(6214):593-5. doi: 10.1136/bmj.280.6214.593.
3
Results of CEA-initiated second-look surgery for recurrent colorectal cancer.癌胚抗原（CEA）引发的复发性结直肠癌二次探查手术的结果。
Am J Surg. 1980 Apr;139(4):544-8. doi: 10.1016/0002-9610(80)90335-9.
4
False-negative results of Hemoccult test in colorectal cancer.大便潜血试验在结直肠癌中的假阴性结果。
Br Med J (Clin Res Ed). 1981 Aug 15;283(6289):472. doi: 10.1136/bmj.283.6289.472.
5
The lesion of the second cancer of the large bowel.大肠第二原发癌的病灶
Br J Surg. 1972 Jan;59(1):16-9. doi: 10.1002/bjs.1800590105.
6
Screening for colon cancer.
Gastroenterology. 1976 May;70(5 PT.1):783-9.
7
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma.血浆癌胚抗原单独及与其他肿瘤标志物联合在结直肠癌和乳腺癌中的监测作用。
Cancer. 1978 Sep;42(3 Suppl):1448-51. doi: 10.1002/1097-0142(197809)42:3+<1448::aid-cncr2820420812>3.0.co;2-w.